UPLC-MS/MS Determination of Phentolamine in Human Plasma and its Application to a Pharmacokinetic Study

 

 Buy Article Permissions and Reprints

Abstract

A sensitive and rapid ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method was developed to determine phentolamine in human plasma. Sample preparation was accomplished through a simple liquid-liquid extraction with ethyl acetate. Chromatographic separation was carried out on an Acquity UPLC BEH C18 column using an isocratic mobile phase system composed of acetonitrile and 1% formic acid in water (33:67, v/v) at a flow rate of 0.45 mL/min. Mass spectrometric analysis was performed using a QTrap5500 mass spectrometer coupled with an electro-spray ionization (ESI) source in the positive ion mode. The MRM transitions of m/z 282.1 → 212.0 and m/z 237.1 → 194.2 were used to quantify for phentolamine and carbamazepine (internal standard, IS), respectively. The linearity of this method was found to be within the concentration range of 0.5–100.0 ng/mL with a lower limit of quantification of 0.5 ng/mL. Only 1.0 min was needed for an analytical run. This fully validated method was successfully applied to the pharmacokinetic study after oral administration of 60 mg phentolamine to 20 Chinese healthy male volunteers.

• References

• 1 Moore PA, Hersh EV, Papas AS et al. Pharmacokinetics of lidocaine with epinephrine following local anesthesia reversal with phentolamine mesylate. Anesth Prog 2008; 55: 40-48
  CrossrefPubMedGoogle Scholar
• 2 Hersh EV, Moore PA, Papas AS et al. Reversal of soft-tissue local anesthesia with phentolamine mesylate in adolescents and adults. J Am Dent Assoc 2008; 139: 1080-1093
  CrossrefPubMedGoogle Scholar
• 3 Elmore S, Nusstein J, Drum M et al. Reversal of Pulpal and Soft Tissue Anesthesia by Using Phentolamine: A Prospective Randomized, Single-blind Study. J Endod 2013; 39: 429-434
  CrossrefPubMedGoogle Scholar
• 4 Tavares M, Goodson JM, Studen-Pavlovich D et al. Reversal of soft-tissue local anesthesia with phentolamine mesylate in pediatric patients. J Am Dent Assoc 2008; 139: 1095-1104
  CrossrefPubMedGoogle Scholar
• 5 Moradkhan R, Spitnale B, McQuillan P et al. Hypoxia-induced vasodilation and effects of regional phentolamine in awake patients with sleep apnea. J Appl Physiol 2010; 108: 1234-1240
  CrossrefPubMedGoogle Scholar
• 6 Laviola M, McGavin SK, Freer GA et al. Randomized study of phentolamine mesylate for reversal of local anesthesia. J Dent Res 2008; 87: 635-639
  CrossrefPubMedGoogle Scholar
• 7 Froum SJ, Froum SH, Malamed SF. The use of phentolamine mesylate to evaluate mandibular nerve damage following implant placement. Compend Contin Educ Dent 2010; 31 (520) 522-528
  PubMedGoogle Scholar
• 8 Fowler S, Nusstein J, Drum M et al. Reversal of soft-tissue anesthesia in asymptomatic endodontic patients: a preliminary, prospective, randomized, single-blind study. J Endod 2011; 37: 1353-1358
  CrossrefPubMedGoogle Scholar
• 9 Webster GK, Lemmer RR, Greenwald S. Rapid analysis of phentolamine by high-performance liquid chromatography. J Chromatogr Sci 2003; 41: 57-62
  CrossrefPubMedGoogle Scholar
• 10 Kerger BD, James RC, Roberts SM. An assay for phentolamine using high performance liquid chromatography with electrochemical detection. Anal Biochem 1988; 170: 145-151
  CrossrefPubMedGoogle Scholar
• 11 Godbillon J, Carnis G. Determination of the major metabolite of phentolamine in human plasma and urine by high-performance liquid chromatography. J Chromatogr 1981; 222: 461-466
  CrossrefPubMedGoogle Scholar
• 12 de Bros F, Wolshin EM. Determination of phentolamine in blood and urine by high performance liquid chromatography. Anal Chem 1978; 50: 521-525
  CrossrefPubMedGoogle Scholar
• 13 Wu L, Liu J, Zhang Y et al. Development of a HPLC/MS/MS method for simultaneous determination of tinidazole, dyclonine and chlorhexidine in rat plasma and its application in the pharmacokinetic research of a film-forming solution. J Pharm Biomed Anal 2012; 62: 224-227
  CrossrefPubMedGoogle Scholar
• 14 Wu JT. The development of a staggered parallel separation liquid chromatography/tandem mass spectrometry system with on-line extraction for high-throughout screening of drug candidates in biological fluids. Rapid Commun Mass Spectrom 2001; 15: 73-81
  CrossrefPubMedGoogle Scholar
• 15 Silva LF, Moraes MO, Santana GS et al. Phentolamine bioequivalence study. Int J Clin Pharmacol Ther 2004; 42: 43-49
  PubMedGoogle Scholar
• 16 Mikami E, Ohno T, Matsumoto H. Simultaneous identification/determination system for phentolamine and sildenafil as adulterants in soft drinks advertising roborant nutrition. Forensic Sci Int 2002; 130: 140-146
  CrossrefPubMedGoogle Scholar
• 17 Xing LL, Tang YH, Wang ZC et al. Sensitive chemiluminescence determination of phentolamine mesylate and phenoxybenzamine hydrochloride based on K3Fe(CN)(6)-H2O2-fluorescein. Journal of Luminescence 2013; 137: 162-167
  CrossrefPubMedGoogle Scholar
• 18 Huang Y, Liu W. Flow-injection chemiluminescence determination of phentolamine based on its enhancing effect on the luminol-potassium ferricyanide system. J Pharm Biomed Anal 2005; 38: 537-542
  CrossrefPubMedGoogle Scholar
• 19 de Villiers A, Lestremau F, Szucs R et al. Evaluation of ultra performance liquid chromatography. Part I. Possibilities and limitations. J Chromatogr A 2006; 1127: 60-69
  CrossrefPubMedGoogle Scholar
• 20 Jamalapuram S, Vuppala PK, Abdelazeem AH et al. Ultra-performance liquid chromatography tandem mass spectrometry method for the determination of AZ66, a sigma receptor ligand, in rat plasma and its application to in vivo pharmacokinetics. Biomed Chromatogr 2013; 27: 1034-1040
  PubMedGoogle Scholar